TOLERACELL
Live / Applied — Second extension granted (statement of use) (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 11 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97307429
- Mark type
- Stylized text
- Filed
- 11 Mar 2022
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Stephen G. Anderson
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for medical use for regulating the immune system
Owner
- Diabetes Free, Inc, New York, NY, US
- Diabetes Free, Inc, New York, NY, US
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 2 GRANTED
- 29 Oct 2025 — SOU EXTENSION 2 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 1 GRANTED
- 28 Apr 2025 — SOU EXTENSION 1 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Sept 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 08 Aug 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER